Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Phase 2 Study in Patients With MiT Tumors
      Description

      This is a multi-center, single arm intended to evaluate the anti-tumor effect of ARQ 197 in patients with microphthalmia transcription factor associated (MiT) tumors. MiT tumors include clear cell sarcoma, alveolar soft parts sarcoma, and translocation associated renal cell carcinoma.

      Conditions
      Renal Cell Carcinoma (RCC)Alveolar Soft Part Sarcoma (ASPS)Clear Cell Sarcoma (CCS)
      Talk to us